On June 5, 2023, Jean-François Formela notified Intellia Therapeutics, Inc. of his intent to resign from the Board of Directors of the Company and its committees, effective June 15, 2023. Mr. Formela currently serves on the Audit Committee and on the Compensation and Talent Development Committee of the Board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.73 USD | -0.96% | +6.31% | -25.45% |
Jun. 03 | Intellia Therapeutics Shares Rise as NTLA-2002 Phase 1 Study Observes 98% Mean Reduction in Monthly Attack Rate | MT |
Jun. 03 | Transcript : Intellia Therapeutics, Inc. - Special Call |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.45% | 2.19B | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- NTLA Stock
- News Intellia Therapeutics, Inc.
- Intellia Therapeutics, Inc. Announces Resignation of Jean-François Formela as Board Member